What Analyst Projections for Key Metrics Reveal About Altria (MO) Q3 Earnings

27.10.25 14:15 Uhr

Werte in diesem Artikel
Aktien

55,48 EUR -0,23 EUR -0,41%

Indizes

PKT PKT

18.111,4 PKT 74,0 PKT 0,41%

3.446,4 PKT 50,7 PKT 1,49%

6.875,2 PKT 83,5 PKT 1,23%

The upcoming report from Altria (MO) is expected to reveal quarterly earnings of $1.44 per share, indicating an increase of 4.4% compared to the year-ago period. Analysts forecast revenues of $5.32 billion, representing a decline of 0.4% year over year.The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.Given this perspective, it's time to examine the average forecasts of specific Altria metrics that are routinely monitored and predicted by Wall Street analysts.Analysts expect 'Revenues net of excise taxes- Oral tobacco products' to come in at $713.65 million. The estimate indicates a year-over-year change of +2.7%.The combined assessment of analysts suggests that 'Revenues net of excise taxes- Smokeable Products' will likely reach $4.64 billion. The estimate points to a change of -0.2% from the year-ago quarter.Based on the collective assessment of analysts, 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' should arrive at $486.18 million. The estimate compares to the year-ago value of $464.00 million.According to the collective judgment of analysts, 'Adjusted OCI- Smokeable Products' should come in at $3.00 billion. Compared to the current estimate, the company reported $2.94 billion in the same quarter of the previous year. View all Key Company Metrics for Altria here>>> Altria shares have witnessed a change of -1.6% in the past month, in contrast to the Zacks S&P 500 composite's +2.5% move. With a Zacks Rank #2 (Buy), MO is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Altria und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Altria

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Altria

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Altria Inc.

Wer­bung

Analysen zu Altria Inc.

DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
31.07.2017Altria Sector PerformRBC Capital Markets
DatumRatingAnalyst
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
27.06.2016Altria Group BuyStifel, Nicolaus & Co., Inc.
02.02.2015Altria Group BuyStifel, Nicolaus & Co., Inc.
31.10.2014Altria Group BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria Sector PerformRBC Capital Markets
09.08.2012Altria Group neutralCitigroup Corp.
26.07.2012Altria Group neutralUBS AG
DatumRatingAnalyst
23.03.2017Altria Group UnderperformRBC Capital Markets
27.04.2005Update UST Inc.: UnderperformGoldman Sachs
27.04.2005UST: UnderweightJP Morgan
24.01.2005UST: UnderweightJP Morgan

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Altria Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen